Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post-hoc analysis of the EXTEND study

被引:1
作者
Meyer, Oliver [1 ]
Wong, Raymond S. M. [2 ]
Khelif, Abderrahim [3 ]
Stankovic, Miona [4 ]
Maier, Joan [4 ]
Saleh, Mansoor N. [5 ]
Bussel, James B. [6 ]
机构
[1] Charite Univ Med Berlin, Inst Transfus Med, Berlin, Germany
[2] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Med & Therapeut, Hong Kong, Peoples R China
[3] Univ Sousse, Hop Univ Farhat Hached, Sousse, Tunisia
[4] Novartis Pharma AG, Basel, Switzerland
[5] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL USA
[6] Weill Cornell Med, Div Pediat Hematol Oncol, New York, NY USA
关键词
eltrombopag; efficacy; immune thrombocytopenia; rituximab; safety; DOUBLE-BLIND; LONG-TERM; EFFICACY; MANAGEMENT; PURPURA; SAFETY;
D O I
10.1111/bjh.17800
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:448 / 452
页数:5
相关论文
共 11 条
[1]   Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials [J].
Bussel, James ;
Arnold, Donald M. ;
Grossbard, Elliot ;
Mayer, Jiri ;
Trelinski, Jacek ;
Homenda, Wojciech ;
Hellmann, Andrzej ;
Windyga, Jerzy ;
Sivcheva, Liliya ;
Khalafallah, Alhossain A. ;
Zaja, Francesco ;
Cooper, Nichola ;
Markovtsov, Vadim ;
Zayed, Hany ;
Duliege, Anne-Marie .
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) :921-930
[2]   Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura [J].
Bussel, James B. ;
Cheng, Gregory ;
Saleh, Mansoor N. ;
Psaila, Bethan ;
Kovaleva, Lidia ;
Meddeb, Balkis ;
Kloczko, Janusz ;
Hassani, Habib ;
Mayer, Bhabita ;
Stone, Nicole L. ;
Arning, Michael ;
Provan, Drew ;
Jenkins, Julian M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22) :2237-2247
[3]   Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP) [J].
Bussel, James B. ;
Saleh, Mansoor N. ;
Vasey, Sandra Y. ;
Mayer, Bhabita ;
Arning, Michael ;
Stone, Nicole L. .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (04) :538-546
[4]   Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial [J].
Bussel, James B. ;
Provan, Drew ;
Shamsi, Tahir ;
Cheng, Gregory ;
Psaila, Bethan ;
Kovaleva, Lidia ;
Salama, Abdulgabar ;
Jenkins, Julian M. ;
Roychowdhury, Debasish ;
Mayer, Bhabita ;
Stone, Nicole ;
Arning, Michael .
LANCET, 2009, 373 (9664) :641-648
[5]   Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study [J].
Cheng, Gregory ;
Saleh, Mansoor N. ;
Marcher, Claus ;
Vasey, Sandra ;
Mayer, Bhabita ;
Aivado, Manuel ;
Arning, Michael ;
Stone, Nicole L. ;
Bussel, James B. .
LANCET, 2011, 377 (9763) :393-402
[6]   Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial [J].
Kuter, David J. ;
Bussel, James B. ;
Lyons, Roger M. ;
Pullarkat, Vinod ;
Gernsheimer, Terry B. ;
Senecal, Francis M. ;
Aledort, Louis M. ;
George, James N. ;
Kessler, Craig M. ;
Sanz, Miguel A. ;
Liebman, Howard A. ;
Slovick, Frank T. ;
de Wolf, J. Th M. ;
Bourgeois, Emmanuelle ;
Guthrie, Troy H., Jr. ;
Newland, Adrian ;
Wasser, Jeffrey S. ;
Hamburg, Solomon I. ;
Grande, Carlos ;
Lefrere, Francois ;
Lichtin, Alan Eli ;
Tarantino, Michael D. ;
Terebelo, Howard R. ;
Viallard, Jean-Francois ;
Cuevas, Francis J. ;
Go, Ronald S. ;
Henry, David H. ;
Redner, Robert L. ;
Rice, Lawrence ;
Schipperus, Martin R. ;
Guo, D. Matthew ;
Nichol, Janet L. .
LANCET, 2008, 371 (9610) :395-403
[7]   American Society of Hematology 2019 guidelines for immune thrombocytopenia [J].
Neunert, Cindy ;
Terrell, Deirdra R. ;
Arnold, Donald M. ;
Buchanan, George ;
Cines, Douglas B. ;
Cooper, Nichola ;
Cuker, Adam ;
Despotovic, Jenny M. ;
George, James N. ;
Grace, Rachael F. ;
Kuehne, Thomas ;
Kuter, David J. ;
Lim, Wendy ;
McCrae, Keith R. ;
Pruitt, Barbara ;
Shimanek, Hayley ;
Vesely, Sara K. .
BLOOD ADVANCES, 2019, 3 (23) :3829-3866
[8]  
Novartis Europharm Limited, 2021, REV ELTR SUMM PROD C
[9]   Updated international consensus report on the investigation and management of primary immune thrombocytopenia [J].
Provan, Drew ;
Arnold, Donald M. ;
Bussel, James B. ;
Chong, Beng H. ;
Cooper, Nichola ;
Gernsheimer, Terry ;
Ghanima, Waleed ;
Godeau, Bertrand ;
Jose Gonzalez-Lopez, Tomas ;
Grainger, John ;
Hou, Ming ;
Kruse, Caroline ;
McDonald, Vickie ;
Michel, Marc ;
Newland, Adrian C. ;
Pavord, Sue ;
Rodeghiero, Francesco ;
Scully, Marie ;
Tomiyama, Yoshiaki ;
Wong, Raymond S. ;
Zaja, Francesco ;
Kuter, David J. .
BLOOD ADVANCES, 2019, 3 (22) :3780-3817
[10]   Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study [J].
Saleh, Mansoor N. ;
Bussel, James B. ;
Cheng, Gregory ;
Meyer, Oliver ;
Bailey, Christine K. ;
Arning, Michael ;
Brainsky, Andres .
BLOOD, 2013, 121 (03) :537-545